FDA Proposes a Tier-Based Approach to Evaluate “Bioequivalence” of Abuse Deterrence of Generic SODF Opioids

FDA Proposes a Tier-Based Approach to Evaluate “Bioequivalence” of Abuse Deterrence of Generic SODF Opioids

Submitted by admin on March 25, 2016 - 9:29am
Source: 
FDA Law Blog
News Tags: 
FDA
generics
opioids
abuse-resistant painkillers
Headline: 
FDA Proposes a Tier-Based Approach to Evaluate “Bioequivalence” of Abuse Deterrence of Generic SODF Opioids

Do Not Allow Advertisers to Use My Personal information